These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31877423)

  • 1. A systematic review of case studies testing a melatonergic agonist/ 5HT
    Coles ME; Goodman MH
    J Anxiety Disord; 2020 Jan; 69():102173. PubMed ID: 31877423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is circadian rhythm disruption important in obsessive-compulsive disorder (OCD)? A case of successful augmentation with agomelatine for the treatment of OCD.
    da Rocha FF; Correa H
    Clin Neuropharmacol; 2011; 34(4):139-40. PubMed ID: 21768800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed Sleep Timing in Obsessive-Compulsive Disorder Is Associated With Diminished Response to Exposure and Ritual Prevention.
    Coles ME; Schubert J; Nota JA
    Behav Ther; 2021 Sep; 52(5):1277-1285. PubMed ID: 34452679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of agomelatine in OCD: effects on the motivational aspects and dysregulated circadian rhythms.
    Perugi G; Quaranta G; Bucci N
    Expert Opin Investig Drugs; 2015 May; 24(5):705-13. PubMed ID: 25727766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circadian rhythms in obsessive-compulsive disorder.
    Lange KW; Lange KM; Hauser J; Tucha L; Tucha O
    J Neural Transm (Vienna); 2012 Oct; 119(10):1077-83. PubMed ID: 22543530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sleep duration and timing in obsessive-compulsive disorder (OCD): evidence for circadian phase delay.
    Coles ME; Schubert J; Stewart E; Sharkey KM; Deak M
    Sleep Med; 2020 Aug; 72():111-117. PubMed ID: 32575000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed Bedtimes Are Associated With More Severe Obsessive-Compulsive Symptoms in Intensive Residential Treatment.
    Nota JA; Potluri S; Kelley KN; Elias JA; Krompinger JW
    Behav Ther; 2020 Jul; 51(4):559-571. PubMed ID: 32586430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed circadian rhythms and insomnia symptoms in obsessive-compulsive disorder.
    Cox RC; Olatunji BO
    J Affect Disord; 2022 Dec; 318():94-102. PubMed ID: 36057288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sleep, arousal, and circadian rhythms in adults with obsessive-compulsive disorder: a meta-analysis.
    Nota JA; Sharkey KM; Coles ME
    Neurosci Biobehav Rev; 2015 Apr; 51():100-7. PubMed ID: 25603315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circadian Rhythms in Obsessive-Compulsive Disorder: Recent Findings and Recommendations for Future Research.
    Cox RC; Olatunji BO
    Curr Psychiatry Rep; 2019 Jun; 21(7):54. PubMed ID: 31165330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic potential of agomelatine in epilepsy and epileptic complications.
    Vimala PV; Bhutada PS; Patel FR
    Med Hypotheses; 2014 Jan; 82(1):105-10. PubMed ID: 24314750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agomelatine in depressive disorders: its novel mechanisms of action.
    Srinivasan V; Zakaria R; Othman Z; Lauterbach EC; Acuña-Castroviejo D
    J Neuropsychiatry Clin Neurosci; 2012; 24(3):290-308. PubMed ID: 23037643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obsessive-compulsive symptoms and characteristics in individuals with delayed sleep phase disorder.
    Schubert JR; Coles ME
    J Nerv Ment Dis; 2013 Oct; 201(10):877-84. PubMed ID: 24080675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Later Bedtimes Predict Prospective Increases in Symptom Severity in Individuals with Obsessive Compulsive Disorder (OCD): An Initial Study.
    Schubert JR; Stewart E; Coles ME
    Behav Sleep Med; 2020; 18(4):500-512. PubMed ID: 31151357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case-control study of sleep disturbances in pediatric obsessive-compulsive disorder.
    Jaspers-Fayer F; Lin SY; Belschner L; Mah J; Chan E; Bleakley C; Ellwyn R; Simpson A; McKenney K; Stewart SE
    J Anxiety Disord; 2018 Apr; 55():1-7. PubMed ID: 29529448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addressing circadian rhythm disturbances in depressed patients.
    Lam RW
    J Psychopharmacol; 2008 Sep; 22(7 Suppl):13-8. PubMed ID: 18753278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compulsion or chronobiology? A case of severe obsessive-compulsive disorder treated with cognitive-behavioral therapy augmented with chronotherapy.
    Coles ME; Sharkey KM
    J Clin Sleep Med; 2011 Jun; 7(3):307-9. PubMed ID: 21677902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of agomelatine, a MT1/MT2 receptor agonist with 5-HT2C antagonistic properties, in major depressive disorder.
    Olié JP; Kasper S
    Int J Neuropsychopharmacol; 2007 Oct; 10(5):661-73. PubMed ID: 17477888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging targets for the pharmacological treatment of depression: focus on melatonergic system.
    Catena-Dell'Osso M; Marazziti D; Rotella F; Bellantuono C
    Curr Med Chem; 2012; 19(3):428-37. PubMed ID: 22335516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melatonergic drugs in clinical practice.
    Hardeland R; Poeggeler B; Srinivasan V; Trakht I; Pandi-Perumal SR; Cardinali DP
    Arzneimittelforschung; 2008; 58(1):1-10. PubMed ID: 18368944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.